Knee Bursitis Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033 | Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Amgen Inc

The knee bursitis from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Knee Bursitis Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The knee bursitis market size has grown strongly in recent years. It will grow from $2.48 billion in 2023 to $2.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%.  The growth in the historic period can be attributed to an aging population, increased participation in sports and physical activities, improved diagnostic techniques, improved access to healthcare services, and education programs for healthcare professionals and patients.

The knee bursitis market size is expected to see strong growth in the next few years. It will grow to $3.54 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.  The growth in the forecast period can be attributed to increased awareness campaigns about prevention and management, growth in disposable income, rising healthcare expenditure, and increasing awareness and diagnosis of knee bursitis. Major trends in the forecast period include advancements in diagnostic techniques, the development of novel therapies, advancements in research and development activities, and telemedicine and remote monitoring.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Scope Of Knee Bursitis Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Knee Bursitis Market Overview

Market Drivers –
The increasing prevalence of bone-related diseases is expected to propel the growth of the knee bursitis market going forward. Bone-related diseases encompass conditions such as osteoporosis, arthritis, and bone cancer, affecting the structure, strength, and function of the skeletal system. The increasing prevalence of bone-related diseases is attributed to factors such as aging populations, sedentary lifestyles, poor nutrition, and environmental changes. Bone-related diseases such as osteoarthritis and rheumatoid arthritis can lead to knee bursitis by causing inflammation and excessive pressure on the knee bursa. This inflammation results in pain, swelling, and reduced joint function. For instance, in September 2022, a report by Healthy Bones Australia, an Australia-based non-profit organization, projected that in 2022, Australia is estimated to have 6.2 million individuals aged 50 and above suffering from osteoporosis or osteopenia. This calculation is based on the fact that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Therefore, the increasing prevalence of bone-related retailers is driving the growth of the knee bursitis market.

Rising Diabetic Population Fuels Growth In Knee Bursitis Market
The increasing diabetic population is expected to propel the growth of the knee bursitis market going forward. Diabetes is a chronic condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or ineffective insulin use. The rise in diabetic cases can be attributed to factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. Diabetic patients may develop knee bursitis due to inflammation caused by prolonged pressure on the knees, impaired immune function, or complications related to diabetes. For instance, in July 2021, according to a report by the International Diabetes Federation, a Belgium-based national diabetes association, the total number of people living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Three out of four adults with diabetes reside in low- and middle-income countries. Therefore, the increasing diabetic population is driving the growth of the knee bursitis market.

Increasing Geriatric Population Fuels Knee Bursitis Market Growth
The increasing geriatric population is expected to propel the growth of the knee bursitis market going forward. The geriatric population refers to individuals typically aged 65 years and older, characterized by specific health considerations related to aging. The geriatric population is rising due to advancements in healthcare leading to longer life expectancy and declining birth rates in many regions globally. The geriatric population commonly experiences knee bursitis due to age-related joint wear and tear, leading to inflammation of the bursae sacs around the knee joint. For instance, in October 2022, according to the World Health Organization, a Switzerland-based health agency, the global population aged 60 years and over is set to increase significantly, from 1 billion in 2020 to 1.4 billion by 2030, reaching 2.1 billion by 2050. Concurrently, the number of individuals aged 80 years or older is expected to triple, reaching 426 million by 2050. Therefore, the increasing geriatric population is driving the growth of the knee bursitis market.

Market Trends –
The knee bursitis market consists of revenues earned by entities by providing services such as medical consultation, medication management, surgical intervention, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The knee bursitis market also includes sales of knee braces and supports, cold packs and heat wraps, anti-inflammatory medications, and corticosteroid injections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The knee bursitis market covered in this report is segmented –
1) By Diagnosis: Imaging Test, Other Diagnosis Tests
2) By Treatment: Medication, Therapy, Surgery, Other Treatments
3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Get an inside scoop of the knee bursitis market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Regional Insights –
North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Table of Contents
1. Executive Summary
2. Knee Bursitis Market Report Structure
3. Knee Bursitis Market Trends And Strategies
4. Knee Bursitis Market – Macro Economic Scenario
5. Knee Bursitis Market Size And Growth
……
27. Knee Bursitis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the trending research reports from TBRC:
https://topprnews.com/gluten-feed-market

https://topprnews.com/organic-feed-market

https://topprnews.com/organic-pigments-market

https://goodprnews.com/rapeseed-oil-market

https://goodprnews.com/gluten-feed-market

https://goodprnews.com/manufactured-soil-market

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info

Healthcare Blog: https://healthcareresearchreports.com

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model